The end of cancer? These 26 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
To be a shareholder in Marcus & Millichap, you have to believe in a rebound in commercial real estate transactions and the company's potential to expand via acquisitions, offsetting near-term earnings declines. The recent Q2 results, showing higher revenue but a wider net loss, highlight that while top-line growth continues, profitability is still challenged. This news has not materially changed the biggest catalyst, which remains a recovery in transaction volume, or the risk posed by transaction-dependent earnings.
Among recent announcements, the affirmation of a semi-annual dividend of US$0.25 per share stands out. Even with persistent net losses, the continued dividend may interest investors seeking income, though it highlights the tension between rewarding shareholders now and funding expenses as revenues recover.
On the other hand, investors should be aware that volatility in transaction activity continues to expose Marcus & Millichap to ...
Read the full narrative on Marcus & Millichap (it's free!)
Marcus & Millichap's outlook forecasts $1.1 billion in revenue and $64.4 million in earnings by 2028. This assumes annual revenue growth of 15.9% and a $71.2 million increase in earnings from the current -$6.8 million.
Uncover how Marcus & Millichap's forecasts yield a $30.00 fair value, a 3% upside to its current price.
Private investors in the Simply Wall St Community see Marcus & Millichap’s fair value between US$54.66 and US$68.76, based on two distinct estimates. Despite this, transaction-dependent earnings volatility remains a focal point for your ongoing research.
Explore 2 other fair value estimates on Marcus & Millichap - why the stock might be worth just $54.66!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Our top stock finds are flying under the radar-for now. Get in early:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocks
Try a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。